Hairlossand potential treatments, primarily focusing on Finasteride and Minoxidil. Other solutions discussed include PRP, dermarolling, LLP, and scalp tension relief.
Addressing hairloss by focusing on posture, blood flow, and craniofacial development. Methods include improving posture, cardiovascular activity, scalp massages, healthy diet, meditation, using minoxidil, and addressing craniofacial issues.
The conversation discusses the delay in the release of a new hairloss treatment, Pyrilutamide, and speculates on potential safety concerns as a reason for the delay. It also mentions GT20029 as another future treatment option, with a release at least five years away, and touches on the avoidance of research chemicals due to uncertainty about their authenticity.
PP405 is considered as a potential hair regrowth treatment, but users are skeptical due to past product failures. They compare it to Minoxidil and Finasteride, questioning its effectiveness and the intentions of pharmaceutical companies.
Whether Finasteride can keep alive the hair gained by Minoxidil after quitting it, and why beard hairs are not as susceptible to miniaturization. It is suggested that scalp hair may be dependent on Minoxidil and that DHT could be countered with Finasteride to some extent, but there is no definitive data proving this.
Scalp Botox may help hairloss by relaxing muscles and increasing blood flow, potentially benefiting conditions other than androgenetic alopecia. DHT affects hair follicles differently, causing tension and hairloss in some areas but not others.
Hairloss theory involves 3alpha-hydroxysteroid reductase (3AHD) converting DHT to androstenol. Discussion explores potential treatments and encourages more research.
The review discusses traditional hairloss treatments like minoxidil and finasteride, and newer options like Low-Level Laser Therapy, microneedling, and platelet-rich plasma for androgenetic alopecia. It highlights the need for more high-quality trials to assess these treatments' effectiveness and standardized protocols for emerging therapies.
Botox is found to be as effective as finasteride in treating hairloss. Users discuss combining treatments like botox, minoxidil, and massages for better results.
Hairloss therapies focusing on hair follicle sugar metabolism and aldose reductase. Potential treatments include magnesium supplements, avoiding high glycemic index foods, and antioxidants.
Body hair transplants can be a last resort for hairloss, using body hair to fill scalp gaps, though it may not match scalp hair in texture or length. Minoxidil and finasteride are discussed as treatments, with varying effectiveness and side effects.
Botox injections may be more effective than finasteride for hair growth by reducing scalp tension. The discussion also suggests choosing FUE over FUT due to potential loss of scalp elasticity with FUT.
Dutasteride promotes more hair regrowth than Minoxidil. Users discuss combining treatments for better results and share personal experiences with side effects.
A user experienced significant hair regrowth and stopped hairlossafter taking 0.5mg of dutasteride daily for a month, without using minoxidil. They reported no side effects and were pleased with the results.
A 25-year-old is struggling with hairloss despite using treatments like oral Minoxidil, oral and topical Finasteride, Dutasteride, and PRP sessions. They feel frustrated with inconsistent treatment strategies and are seeking advice on managing thin hairand regaining confidence.
A user reported that after experiencing hair thinning, they started using finasteride in 2024 and later began GHK-Cu peptide injections in March 2026, which they believe stopped their hairlossand made their hair feel thicker. The user shared their experience despite receiving criticism for not solely endorsing finasteride.
The user has been using oral minoxidil for 4 years and durum wheat 3 days a week for 7 months, but is experiencing increased hairloss when washing hair. They suspect it might be due to decreased DHT levels and are seeking similar experiences from others.
Hairloss significantly impacts self-perception and attractiveness, with treatments like finasteride, minoxidil, and hair transplants suggested. The conversation highlights the emotional struggle and societal perceptions tied to hairloss.
A 20-year-old is experiencing hairlossand is using finasteride, ketoconazole, and topical minoxidil. They suspect retrograde alopecia due to hairloss on the sides and nape, despite noticing some hair thickening on top.
Hairloss treatments include topical and oral minoxidil, low-level laser light therapy, and peptide serums. Bryan Johnson avoids finasteride and dutasteride due to potential side effects, focusing instead on his own protocol with these treatments.
A 31-year-old man feels depressed due to hairloss, using topical finasteride and previously tried minoxidil. Others suggest treatments like finasteride, minoxidil, hair transplants, or embracing baldness, highlighting the importance of mental health and self-acceptance.
Hairloss treatments like Breezula and PP405 are delayed, with approvals taking years, while existing treatments like minoxidil and finasteride remain popular. New treatments like Clascoterone and Veradermics are in trials, but high costs and lengthy approval processes slow their release.
Hairloss treatments like Minoxidil, finasteride, and potential mRNA therapies are discussed. There is skepticism about targeting specific genes due to the complex genetic nature of hairloss.
Hairloss treatments are being tested on mice, with methods like minoxidil and stem cell therapy showing promising results. However, human trials are still years away, leading to humorous frustration about mice benefiting first.
Hairloss changes are typically noticed over months or years, not days, and treatments like finasteride, dutasteride, and minoxidil require time to show effects. People often overreact to daily shedding, but realistic expectations and patience are necessary for hair regrowth treatments.
Hairloss may be linked to the TRPS1 gene and protein, not just DHT. Amplifica's AMP-303 targets mesenchymal stem cells and shows promise in treating hairloss, unlike Pelage's PP405.
Hairloss returned after 8 months of using a treatment with .3% Dutasteride and 8% Minoxidil. The user suspects a marketing strategy as the company offers a more expensive product with additional ingredients like biotin and finasteride.